PharmGKB summary: peginterferon-&agr; pathway

S. Shuldiner,L. Gong,A. Muir,R. Altman,T. Klein
DOI: https://doi.org/10.1097/FPC.0000000000000158
2015-09-01
Abstract:Departments of Genetics, Bioengineering, Stanford University, Stanford, California and Duke Clinical Research Institute, Duke University, Durham, North Carolina, USA Correspondence to Teri E. Klein, PhD, Department of Genetics, Stanford School of Medicine, Shriram Center, 443 Via Ortega, Room 213, Stanford University, Stanford, CA 94305-4125, USA Tel: + 1 650 736 0156; fax: + 1 650 725 3863; e-mail: feedback@pharmgkb.org
What problem does this paper attempt to address?